Chung, D.Y.; Kang, D.H.; Kim, J.W.; Kim, D.K.; Lee, J.Y.; Hong, C.H.; Cho, K.S.
Comparison of Oncologic Outcomes between Two Alternative Sequences with Abiraterone Acetate and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis. Cancers 2020, 12, 8.
https://doi.org/10.3390/cancers12010008
AMA Style
Chung DY, Kang DH, Kim JW, Kim DK, Lee JY, Hong CH, Cho KS.
Comparison of Oncologic Outcomes between Two Alternative Sequences with Abiraterone Acetate and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis. Cancers. 2020; 12(1):8.
https://doi.org/10.3390/cancers12010008
Chicago/Turabian Style
Chung, Doo Yong, Dong Hyuk Kang, Jong Won Kim, Do Kyung Kim, Joo Yong Lee, Chang Hee Hong, and Kang Su Cho.
2020. "Comparison of Oncologic Outcomes between Two Alternative Sequences with Abiraterone Acetate and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis" Cancers 12, no. 1: 8.
https://doi.org/10.3390/cancers12010008
APA Style
Chung, D. Y., Kang, D. H., Kim, J. W., Kim, D. K., Lee, J. Y., Hong, C. H., & Cho, K. S.
(2020). Comparison of Oncologic Outcomes between Two Alternative Sequences with Abiraterone Acetate and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis. Cancers, 12(1), 8.
https://doi.org/10.3390/cancers12010008